Ubs Asset Management Americas Inc Liquidia Corp Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Liquidia Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 87,650 shares of LQDA stock, worth $965,026. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,650
Previous 11,500
662.17%
Holding current value
$965,026
Previous $169,000
521.89%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LQDA
# of Institutions
162Shares Held
36MCall Options Held
1.79MPut Options Held
380K-
Patient Square Capital LP Menlo Park, CA7.18MShares$79.1 Million40.01% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$46.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$37.5 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.4MShares$26.4 Million13.89% of portfolio
-
State Street Corp Boston, MA2.23MShares$24.6 Million0.0% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $709M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...